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policy issue The Australian and New Zealand clinical practice guidelines recommend intensive 
case management for people with first-episode psychosis or an acute relapse of 
schizophrenia.1 
Case management is a collaborative, community-based program designed to ensure 
people receive quality health care and integrated support services. Case 
management is often initiated following discharge from hospital or transfer from 
community-based acute care. It involves a nurse, social worker or other clinician 
overseeing a patient’s treatment and wellbeing.2  
Along with drug therapy, case management may provide substantial benefits for 
people suffering severe mental illnesses like schizophrenia. However before case 
management services are made universally available, more work needs to be done 
to determine when, and for whom, these services are most effective. 
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what does the 
evidence say? 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Systematic reviews assess the results of multiple independent studies on a topic. 
They are regarded as a reliable source of research evidence, especially when they 
pool data from individual studies and analyse the combined results (a meta-
analysis). Four systematic reviews have been done on the effectiveness of case 
management for people with schizophrenia.  
The first major systematic review in this area was published in 2007 in the British 
Medical Journal.2 It was primarily concerned with the impact of case management 
for patients with schizophrenia on hospital length of stay. By combining results from 
29 individual randomised controlled trials (RCTs), this review found that patients 
who received case management tended to spend less time in hospital. The shorter 
hospital stays came about because patients received better integrated and 
coordinated care out of hospital. 
Another systematic review, published by the Cochrane Collaboration in 2010, also 
came to the conclusion that case management was beneficial for patients with 
severe mental illnesses.3 In this review, however, researchers looked at the impact 
of intensive case management and compared it with standard community-based 
treatments (for example, ongoing antipsychotic medication with no psychosocial 
intervention). Intensive case management differs from standard case management 
in that it focuses on the integration of services provided by multidisciplinary teams 
whose members, because they have a relatively small caseload (usually less than 10-
20 patients per clinician),2,4 are able to spend more time with each patient. Intensive 
case management is used to care for people with high levels of need, and a high risk 
of relapse and hospital readmission.3 
In the 2010 Cochrane review, 27 RCTs were identified where intensive case 
management was compared with standard treatment.3 Overall results revealed that 
patients undergoing intensive case management had: 
• Fewer days in psychiatric hospitals per month for up to 2 years following 
treatment (these findings were seen in 24 RCTs, but 11 of these RCTs found 
no difference in the total number of hospital admissions over 12 months).  
• More contact with other psychiatric services over 12 months and fewer 
dropouts from treatment over the long-term (findings seen in 9 and 13 
RCTs, respectively). 
• Better overall functioning after 12 months and short-term (<6 months) 
improvements in quality of life (5 RCTs). 
• Lower unemployment rates in the short-term (7-12 months), but this 
difference was not maintained in the longer term (4 RCTs). 
• A greater ability to live independently at 12 months (5 RCTs). 
• Less chance of being homeless in the short-term (<6 months) (1 RCT), but 
this was not found in the longer term (>12 months) (3 RCTs). 
• Some improvement in psychiatric symptoms in the longer term (12 
months), but not in the short-term (2 RCTs). 
When the authors of the 2010 Cochrane review compared standard and intensive 
case management, they found that the only demonstrated benefit of intensive case 
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what does the 
evidence say? 
management was that it lowered treatment dropout rates for up to 12 months 
afterwards.3  There were no differences in other outcomes such as hospitalisation 
and service use, medication compliance, employment, homelessness, substance use, 
mental state or quality of life.3  
Patients with schizophrenia who also have substance abuse problems are 
particularly difficult to treat effectively. Two systematic reviews have examined the 
effectiveness of case management for these people; one was conducted by the 
Cochrane Collaboration in 2008, and the other was published in the Journal of 
Substance Abuse Treatment that same year.5,6 Both of the reviews found there was 
no benefit of intensive case management compared with treatment as usual 
(maintenance antipsychotics) on a range of outcome measures such as overall 
functioning, substance dependence, hospitalisation or service use, and treatment 
adherence. These findings raise questions about the value of intensive case 
management for schizophrenia patients with comorbid substance abuse. 
  
what is the  
quality of the 
evidence available? 
 
The available evidence on the effectiveness of case management services for 
patients with schizophrenia is generally of high quality, with findings consistently 
showing that patients benefit when they receive case management. It is worth 
pointing out, however, that while the two Cochrane reviews on case management 
mentioned above are considered to be high quality evidence because they adhere to 
stringent methodological guidelines, some of the individual studies included in them 
have considerable limitations.3,6 The quality of evidence generated by the 2007 
British Medical Journal review is even less reliable because it included lower quality 
studies than the Cochrane review (i.e. studies other than RCTs), and there was high 
variability between the results of individual studies.2 
One common problem evident with the studies in these systematic reviews is that 
they do not clearly explain how they randomly allocated patients to treatment 
groups (case management or usual care). Random allocation is a key way of ensuring 
that the two patient groups are comparable and that the findings of the study are of 
high quality. Some studies included in the reviews also did not adequately explain 
how they made sure people assessing patient outcomes remained impartial (i.e. 
being ‘blind’ to which treatment group patients were in). 
  
what does this  
mean for  
policymakers? 
The evidence base in this field has some flaws, gaps and inconsistencies. This is not 
uncommon in health services research, and policymakers and health planners are 
often required to make decisions in the absence of very high quality evidence. In 
light of this, policymakers and health planners can be reasonably confident that 
many people with schizophrenia will benefit if they receive case management 
services. However, it is not yet clear whether intensive case management has any 
additional benefits over standard case management. Patients with schizophrenia 
and substance abuse problems do not appear to benefit from case management; 
comorbid substance abuse in schizophrenia is a serious clinical problem for which 
more treatment research is required. 
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